S Ryan1, S J Crinion1, W T McNicholas2. 1. From the Pulmonary and Sleep Disorders Unit, St. Vincent's University Hospital, Dublin, Ireland and School of Medicine and Medical Science, The Conway Institute, University College Dublin, Dublin, Ireland From the Pulmonary and Sleep Disorders Unit, St. Vincent's University Hospital, Dublin, Ireland and School of Medicine and Medical Science, The Conway Institute, University College Dublin, Dublin, Ireland. 2. From the Pulmonary and Sleep Disorders Unit, St. Vincent's University Hospital, Dublin, Ireland and School of Medicine and Medical Science, The Conway Institute, University College Dublin, Dublin, Ireland From the Pulmonary and Sleep Disorders Unit, St. Vincent's University Hospital, Dublin, Ireland and School of Medicine and Medical Science, The Conway Institute, University College Dublin, Dublin, Ireland walter.mcnicholas@ucd.ie.
Abstract
Sleep-disordered breathing (SDB), in particular obstructive sleep apnoea (OSA) and obesity hypoventilation syndrome (OHS) are associated with significant morbidity and mortality. The prevalence of these conditions is rapidly rising mainly due to the worldwide increase in obesity. Obesity contributes to the pathogenesis of SDB in multiple ways including altering upper airway anatomy and collapsibility, ventilatory control and increasing respiratory work load. There is also increasing evidence that OSA itself contributes to the development of obesity. Moreover, both OSA and obesity promote the activation of inflammatory pathways, which is likely a key mechanism in cardiovascular and metabolic disease processes. Early recognition of SDB is important as effective treatments are available. Public health measures to reduce the prevalence of obesity are urgently required to halt the increasing burden of SDB.
Sleep-disordered breathing (SDB), in particular obstructive sleep apnoea (OSA) and obesity hypoventilation syndrome (OHS) are associated with significant morbidity and mortality. The prevalence of these conditions is rapidly rising mainly due to the worldwide increase in obesity. Obesity contributes to the pathogenesis of SDB in multiple ways including altering upper airway anatomy and collapsibility, ventilatory control and increasing respiratory work load. There is also increasing evidence that OSA itself contributes to the development of obesity. Moreover, both OSA and obesity promote the activation of inflammatory pathways, which is likely a key mechanism in cardiovascular and metabolic disease processes. Early recognition of SDB is important as effective treatments are available. Public health measures to reduce the prevalence of obesity are urgently required to halt the increasing burden of SDB.
Authors: Robert J Fleck; Stacey L Ishman; Sally R Shott; Ephraim J Gutmark; Keith B McConnell; Mohamed Mahmoud; Goutham Mylavarapu; Dhananjay R Subramaniam; Rhonda Szczesniak; Raouf S Amin Journal: J Clin Sleep Med Date: 2017-02-15 Impact factor: 4.062
Authors: Maria-Eleni Roumelioti; Christos Argyropoulos; Vernon Shane Pankratz; Manisha Jhamb; Filitsa H Bender; Daniel J Buysse; Patrick Strollo; Mark L Unruh Journal: Can J Kidney Health Dis Date: 2016-02-17